Targeting of NaV1.5 channel in metastatic breast cancer models in vitro and in vivo mice as a novel therapy

dc.contributor.authorErdogan, M. A.
dc.contributor.authorOzpolat, B.
dc.date.accessioned2019-10-27T11:10:32Z
dc.date.available2019-10-27T11:10:32Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.descriptionECCO European Cancer Congress -- JAN 27-30, 2017 -- Amsterdam, NETHERLANDSen_US
dc.description.sponsorshipEuropean Canc Orgen_US
dc.identifier.endpageS43en_US
dc.identifier.issn0959-8049
dc.identifier.issn1879-0852
dc.identifier.startpageS43en_US
dc.identifier.urihttps://hdl.handle.net/11454/32405
dc.identifier.volume72en_US
dc.identifier.wosWOS:000417650200133en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal of Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTargeting of NaV1.5 channel in metastatic breast cancer models in vitro and in vivo mice as a novel therapyen_US
dc.typeConference Objecten_US

Dosyalar